Amsterdam UMC to lead European consortium in search of solutions to stress among surgical team

Es­pe­ri­on has se­cured ma­jor FDA la­bel ex­pan­sions for its two cho­les­terol-low­er­ing drugs, a reg­u­la­to­ry mile­stone that it says opens up a much big­ger mar­ket and

On the heels of FDA’s rejection of midomafetamine (MDMA) for post-traumatic stress disorder (PTSD), the journal Psychopharmacology retracted three papers on MDMA-assisted therapy over data